MedTrace Logo

Introvision for Migraine and Headaches

NCT03507400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-04-18

Study results available
· View outcomes & findings →

Summary

To evaluate the effect of Introvision, a mental and emotional self-regulation-technique developed by Angelika C. Wager, as migraine preventative compared to a waiting list group.

Conditions

Interventions

BEHAVIORAL

Introvision: mental and emotional self-regulation

Participants learn Introvision

Sponsors & Collaborators

  • University of Hamburg-Eppendorf

    collaborator OTHER

  • Introvision e.V

    collaborator UNKNOWN

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Monika Empl, MD · Department of Neurology, Marchioninistr. 15, 81377 Munich, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-20
Primary Completion
2019-09-11
Completion
2020-07-19

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507400 on ClinicalTrials.gov